Plasma homocysteine, a risk factor for cardiovascular disease, is lowered by physiological doses of folic acid.

PubWeight™: 1.21‹?› | Rank: Top 10%

🔗 View Article (PMID 9327030)

Published in QJM on August 01, 1997

Authors

M Ward1, H McNulty, J McPartlin, J J Strain, D G Weir, J M Scott

Author Affiliations

1: Human Nutrition Research Group, University of Ulster, Coleraine, UK.

Articles citing this

Increased prevalence of methylenetetrahydrofolate reductase C677T variant in patients with inflammatory bowel disease, and its clinical implications. Gut (1999) 1.95

Homocysteine and coronary heart disease in the Caerphilly cohort: a 10 year follow up. Heart (2001) 1.49

Preventive health care, 2000 update: screening and management of hyperhomocysteinemia for the prevention of coronary artery disease events. The Canadian Task Force on Preventive Health Care. CMAJ (2000) 1.19

Folic acid fortification and public health: report on threshold doses above which unmetabolised folic acid appear in serum. BMC Public Health (2007) 1.13

The mandatory fortification of staple foods with folic acid: a current controversy in Germany. Dtsch Arztebl Int (2011) 1.09

Folate status of reproductive age women and neural tube defect risk: the effect of long-term folic acid supplementation at doses of 140 µg and 400 µg per day. Nutrients (2011) 0.98

Descriptive study of possible link between cardioankle vascular index and homocysteine in vascular-related diseases. BMJ Open (2013) 0.93

Evaluation of the levels of folate, vitamin B12, homocysteine and fluoride in the parents and the affected neonates with neural tube defect and their matched controls. Pediatr Surg Int (2008) 0.90

Homocysteine and ischaemic stroke in men: the Caerphilly study. J Epidemiol Community Health (2001) 0.89

Dietary choline and betaine intakes and risk of cardiovascular diseases: review of epidemiological evidence. ARYA Atheroscler (2011) 0.89

Folate and homocysteine phenotypes: Comparative findings using research and clinical laboratory data. Clin Biochem (2009) 0.82

The many flavors of hyperhomocyst(e)inemia: insights from transgenic and inhibitor-based mouse models of disrupted one-carbon metabolism. Antioxid Redox Signal (2007) 0.82

Physical activity is inversely associated with total homocysteine levels, independent of C677T MTHFR genotype and plasma B vitamins. Age (Dordr) (2007) 0.81

Exercise mitigates homocysteine - β2-adrenergic receptor interactions to ameliorate contractile dysfunction in diabetes. Int J Physiol Pathophysiol Pharmacol (2011) 0.80

Segment-specific association between plasma homocysteine level and carotid artery intima-media thickness in the Framingham Offspring Study. J Stroke Cerebrovasc Dis (2010) 0.80

Folate and Vitamin B12 Deficiency Among Non-pregnant Women of Childbearing-Age in Guatemala 2009-2010: Prevalence and Identification of Vulnerable Populations. Matern Child Health J (2015) 0.80

Homocysteine lowering by folate-rich diet or pharmacological supplementations in subjects with moderate hyperhomocysteinemia. Nutrients (2013) 0.79

A quantile regression approach can reveal the effect of fruit and vegetable consumption on plasma homocysteine levels. PLoS One (2014) 0.76

Absorption and blood/cellular transport of folate and cobalamin: Pharmacokinetic and physiological considerations. Biochimie (2015) 0.76

Trait anger, hostility, serum homocysteine, and recurrent cardiac events after percutaneous coronary interventions. Am J Crit Care (2009) 0.75

Articles by these authors

The ferric reducing ability of plasma (FRAP) as a measure of "antioxidant power": the FRAP assay. Anal Biochem (1996) 28.76

Ferric reducing/antioxidant power assay: direct measure of total antioxidant activity of biological fluids and modified version for simultaneous measurement of total antioxidant power and ascorbic acid concentration. Methods Enzymol (1999) 5.81

Folate levels and neural tube defects. Implications for prevention. JAMA (1995) 5.42

General practitioner centred scheme for treatment of opiate dependent drug injectors in Glasgow. BMJ (1997) 4.75

Minimum effective dose of folic acid for food fortification to prevent neural-tube defects. Lancet (1997) 4.11

Unmetabolized folic acid in serum: acute studies in subjects consuming fortified food and supplements. Am J Clin Nutr (1997) 3.75

Homocysteine metabolism in pregnancies complicated by neural-tube defects. Lancet (1995) 3.70

Randomized trial of folic acid supplementation and serum homocysteine levels. Arch Intern Med (2001) 3.55

Accuracy of weighed dietary records in studies of diet and health. BMJ (1990) 3.45

Translocation as a species conservation tool: status and strategy. Science (1989) 3.31

Maternal plasma folate and vitamin B12 are independent risk factors for neural tube defects. Q J Med (1993) 2.69

Randomised comparison of olsalazine and mesalazine in prevention of relapses in ulcerative colitis. Lancet (1992) 2.63

Effect of increasing dietary folate on red-cell folate: implications for prevention of neural tube defects. Lancet (1996) 2.53

Congenital toxoplasmosis: a prospective survey in the West of Scotland. J Infect (1981) 2.52

Microbiological assay for serum, plasma, and red cell folate using cryopreserved, microtiter plate method. Methods Enzymol (1997) 2.40

Screening for organic mental syndromes in the medically ill. Ann Intern Med (1977) 2.28

Importance of both folic acid and vitamin B12 in reduction of risk of vascular disease. Lancet (2002) 2.25

Increased incidence of non-Hodgkin's lymphoma in inflammatory bowel disease patients on immunosuppressive therapy but overall risk is low. Gut (2000) 2.17

Drug names that look or sound alike. Br Med J (1979) 2.16

Operationalizing a bedside pen entry notebook clinical database system in consultation-liaison psychiatry. Gen Hosp Psychiatry (1995) 2.15

Thermolabile variant of 5,10-methylenetetrahydrofolate reductase associated with low red-cell folates: implications for folate intake recommendations. Lancet (1997) 2.10

Endocinch therapy for gastro-oesophageal reflux disease: a one year prospective follow up. Gut (2003) 2.06

A genetic defect in 5,10 methylenetetrahydrofolate reductase in neural tube defects. QJM (1995) 2.05

Increased prevalence of methylenetetrahydrofolate reductase C677T variant in patients with inflammatory bowel disease, and its clinical implications. Gut (1999) 1.95

The "thermolabile" variant of methylenetetrahydrofolate reductase and neural tube defects: An evaluation of genetic risk and the relative importance of the genotypes of the embryo and the mother. Am J Hum Genet (1999) 1.94

Diagnosis of gluten-sensitive enteropathy: is exclusive reliance on histology appropriate? Eur J Gastroenterol Hepatol (1998) 1.87

Validation of estimates of energy intake by weighed dietary record and diet history in children and adolescents. Am J Clin Nutr (1992) 1.84

Neurodevelopmental effects of maternal nutritional status and exposure to methylmercury from eating fish during pregnancy. Neurotoxicology (2008) 1.82

Placental insufficiency and the small-for-dates baby. Am J Obstet Gynecol (1972) 1.72

Homocysteine and ischemic heart disease: results of a prospective study with implications regarding prevention. Arch Intern Med (1998) 1.72

Selective inhibition of inducible nitric oxide synthase inhibits tumor growth in vivo: studies with 1400W, a novel inhibitor. Cancer Res (1997) 1.71

Riboflavin lowers homocysteine in individuals homozygous for the MTHFR 677C->T polymorphism. Circulation (2005) 1.70

Primary biliary cirrhosis and coeliac disease: an association? Lancet (1978) 1.70

Impaired functioning of thermolabile methylenetetrahydrofolate reductase is dependent on riboflavin status: implications for riboflavin requirements. Am J Clin Nutr (2002) 1.68

Status and prospects for success of the endangered species act: a look at recovery plans. Science (1993) 1.68

Vitamin B12 and folate deficiency in later life. Age Ageing (2004) 1.67

Estimation of the dietary requirement for vitamin D in healthy adults. Am J Clin Nutr (2008) 1.65

Lipoprotein(a) in cirrhosis. BMJ (1992) 1.63

Alpha gliadin antibody levels: a serological test for coeliac disease. Br Med J (Clin Res Ed) (1983) 1.62

An improved serodiagnostic procedure for visceral leishmaniasis. Am J Trop Med Hyg (1990) 1.61

Humoral response to wheat protein in patients with coeliac disease and enteropathy associated T cell lymphoma. Br Med J (Clin Res Ed) (1986) 1.59

Genetic and nutritional factors contributing to hyperhomocysteinemia in young adults. Blood (2003) 1.57

Elevated plasma homocysteine in early pregnancy: a risk factor for the development of severe preeclampsia. Am J Obstet Gynecol (2001) 1.55

Estimation of the dietary requirement for vitamin D in free-living adults >=64 y of age. Am J Clin Nutr (2009) 1.54

Localisation of the vaso-motor centre. J Physiol (1923) 1.51

Olsalazine is not superior to placebo in maintaining remission of inactive Crohn's colitis and ileocolitis: a double blind, parallel, randomised, multicentre study. Gut (2001) 1.48

High multidrug resistance (P-glycoprotein 170) expression in inflammatory bowel disease patients who fail medical therapy. Gastroenterology (2000) 1.47

Adipose tissue trans fatty acids and breast cancer in the European Community Multicenter Study on Antioxidants, Myocardial Infarction, and Breast Cancer. Cancer Epidemiol Biomarkers Prev (1997) 1.46

Daily energy expenditure in free-living children: comparison of heart-rate monitoring with the doubly labeled water (2H2(18)O) method. Am J Clin Nutr (1992) 1.45

The relationship between increased folate catabolism and the increased requirement for folate in pregnancy. BJOG (2000) 1.42

Patient noncompliance with self-administered chemotherapy. Cancer (1990) 1.40

In vitro studies of suppressor cell function in human peripheral blood mononuclear cells. Clin Exp Immunol (1978) 1.39

The sequencing of psychiatric recommendations. Concordance during the process of a psychiatric consultation. Psychosomatics (1993) 1.38

Women and the GMC. Br Med J (Clin Res Ed) (1985) 1.38

Methylenetetrahydrofolate reductase thermolabile variant and oral clefts. Am J Med Genet (1999) 1.37

The elucidation of the mechanism of folate catabolism in the rat. Biochem Biophys Res Commun (1976) 1.34

Absence of oats toxicity in adult coeliac disease. BMJ (1996) 1.34

The methyl folate trap. A physiological response in man to prevent methyl group deficiency in kwashiorkor (methionine deficiency) and an explanation for folic-acid induced exacerbation of subacute combined degeneration in pernicious anaemia. Lancet (1981) 1.33

Increased severity and morbidity of acute hepatitis in drug abusers with simultaneously acquired hepatitis B and hepatitis D virus infections. Br Med J (Clin Res Ed) (1985) 1.29

Coeliac disease during the teenage period: the value of serial serum folate estimations. Gut (1974) 1.26

The part played by the ala cinerea in vaso-motor reflexes. J Physiol (1925) 1.25

Pathogenesis of subacute combined degeneration: a result of methyl group deficiency. Lancet (1981) 1.25

Nutritional factors may modify the toxic action of methyl mercury in fish-eating populations. J Nutr (2003) 1.24

Symptomatic gastro-oesophageal reflux disease: double blind controlled study of intermittent treatment with omeprazole or ranitidine. The European Study Group. BMJ (1999) 1.23

The immune system as a physiological indicator of marginal copper status? Br J Nutr (2002) 1.23

Complex interactions with several arms of the complement system dictate innate and humoral immunity to adenoviral vectors. Gene Ther (2008) 1.21

Chaperone-facilitated copper binding is a property common to several classes of familial amyotrophic lateral sclerosis-linked superoxide dismutase mutants. Proc Natl Acad Sci U S A (1998) 1.21

Nutrient and methyl mercury exposure from consuming fish. J Nutr (2007) 1.20

Fitness, fatness, and coronary heart disease risk in adolescents: the Northern Ireland Young Hearts Project. Med Sci Sports Exerc (2001) 1.20

Attitudes toward genetic testing and personalised nutrition in a representative sample of European consumers. Br J Nutr (2008) 1.19

Immunoperoxidase demonstration of the cellular composition of the normal and coeliac small bowel. Clin Exp Immunol (1987) 1.19

Cellular response to alpha-gliadin in untreated coeliac disease. Gut (1982) 1.18

Use of beta-lactamase to hydrolyse interfering antibiotics in vitamin B12 microbiological assay using Lactobacillus leichmannii. Clin Lab Haematol (1990) 1.18

Fish consumption and prenatal methylmercury exposure: cognitive and behavioral outcomes in the main cohort at 17 years from the Seychelles child development study. Neurotoxicology (2011) 1.18

Identification of a new vitamin B 12 binder (transcobalamin 3) in normal human serum. Br J Haematol (1972) 1.18

Folate coenzymes of Clostridium acidi-urici. The isolation of (l)-5,10-methenyltetrahydropteroyltriglutamate, its conversion to (l)-tetrahydropteroyltriglutamate and (l)-10-( 14 C)formyltetrahydropteroyltriglutamate, and the synthesis of (l)-10-formyl-(6,7- 3 H 2 )tetrahydropteroyltriglutamate and (l)-(6,7- 3 H 2 )tetrahydropteroyltriglutamate. J Biol Chem (1972) 1.17